The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Sickle cell disease in Africa: burden and research priorities
Open accessAbstract
Sickle cell disease (SCD) has recently been recognised as a problem of major public-health significance by the World Health Organization. Despite the fact that >70% of sufferers live in Africa, expenditure on the related care and research in the continent is negligible, and most advances in the understanding and management of this condition have been based on research conducted in the North. In order to target limited resources, African countries need to focus research and interventions on areas that will lead to the maximum impact. This review details the epidemiological and clinical background of SCD, with an emphasis on Africa, before identifying the research priorities that will provide the necessary evidence base for improving the management of African patients. Malaria, bacterial and viral infections and cerebrovascular accidents are areas in which further research may lead to a significant improvement in SCD-related morbidity and mortality. As patients with high concentrations of foetal haemoglobin (HbF) appear to be protected from all but mild SCD, the various factors and pharmacological agents that might increase HbF levels need to be assessed in Africa, as options for interventions that would improve quality of life and reduce mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 4×
“…has shown that the highest levels of SCD-related mortality occur in children aged between 6 months and 3 years, the commonest causes of death being acute chest syndrome (ACS), acute splenic sequestration and pneumococcal septicaemia (Rogers et al., 1978; Leikin et al., 1989; Platt et al., 1994).”
BackgroundInfluentialEffect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340 · cited 4×
“Hydroxyurea has been shown to be effective in influencing several clinical features of SCD (Charache et al., 1995; Ware et al., 1995) and the most appropriate approaches to its use (in terms of treatment longevity, duration and dose) and the selection of patients to receive the drug have been studied extensively, albe…”
BackgroundInfluentialAdams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Bacteremia among Children Admitted to a Rural Hospital in Kenya
Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P. E., Njenga, S., Hart, C. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa040275 · Cited by 851
Self-citationFetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea
Steinberg, M. H., Lu, Z.-H., Barton, F. B., Terrin, M. L., Charache, S., Dover, G. J., & Hydroxyurea, T. M. S. O. (1997) · Blood · doi:10.1182/blood.v89.3.1078 · Cited by 407 · cited 2×
“, 1995) and the most appropriate approaches to its use (in terms of treatment longevity, duration and dose) and the selection of patients to receive the drug have been studied extensively, albeit, again, outside of Africa (Powars et al., 1984; Steinberg et al., 1997).”
BackgroundHaemoglobin C protects against clinical Plasmodium falciparum malaria
Modiano, D., Luoni, G., Sirima, B. S., Simporé, J., Verra, F., Konaté, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G. M., et al. (2001) · Nature · doi:10.1038/35104556 · Cited by 381
Silent cerebral infarcts in sickle cell anemia: a risk factor analysis
Kinney, T. R., Sleeper, L. A., Wang, W. C., Zimmerman, R. A., Pegelow, C. H., Ohene-Frempong, K., Wethers, D. L., Bello, J. A., Vichinsky, E. P., Moser, F. G., et al. (1999) · PEDIATRICS · doi:10.1542/peds.103.3.640 · Cited by 309
Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease
Noguchi, C. T., Rodgers, G. P., Serjeant, G., & Schechter, A. N. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801143180207 · Cited by 222 · cited 1×
“…of the severity of SCD because they interfere with HbS polymerization in erythrocytes, resulting in lower rates of haemolysis and fewer irreversibly sickled cells (Ali, 1970; Haghshenass et al., 1977; Stevens et al., 1981; Powars et al., 1984; Miller et al., 1986; Noguchi et al., 1988).”
Background
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Self-citationGrosse, S. D., Odame, I., Atrash, H. K., Amendah, D. D., Piel, F. B., & Williams, T. N. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.09.013 · Cited by 707
Self-citationInfection in sickle cell disease: A review
Booth, C., Inusa, B., & Obaro, S. K. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.03.010 · Cited by 357
Epidemiology of sickle cell disease in Saudi Arabia
Jastaniah, W. (2011) · Annals of Saudi Medicine · doi:10.4103/0256-4947.81540 · Cited by 289
Ramakrishnan, M., Moïsi, J. C., Klugman, K. P., Iglesias, J. M. F., Grant, L. R., Mpoudi-Etame, M., & Levine, O. S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70055-4 · Cited by 111
Metadata
- Authors
- Makani, J., Williams, T. N., & Marsh, K.
- Venue
- Annals of Tropical Medicine & Parasitology
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 101
- Issue
- 1
- Pages
- 3-14
- ISSN
- 0003-4983 (ISSN-L)
- 1364-8594
- OpenAlex
- W1968566976
- Cited by
- 171
- References
- 9
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sickle cell disease in Africa: burden and research priorities. https://app.cochat.ai/papers/10.1179/136485907x154638
- The paper
- Makani, J., Williams, T. N., & Marsh, K. (2007). Sickle cell disease in Africa: burden and research priorities. Annals of Tropical Medicine & Parasitology. https://doi.org/10.1179/136485907x154638
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.